−61.5
Alaunos Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−29.2
FY23:
−30.1
FY24:
−4.97
FY25:
−2.87
Change from FY21 to FY25
millions USD
FY21:
−3.32
FY22:
−0.19
FY23:
1.35
FY24:
0
FY25:
−0.10
Change from FY21 to FY25
millions USD
FY21:
25.8
FY22:
6.37
FY23:
−18.1
FY24:
0
FY25:
3.26
millions USD
FY21:
−39.0
FY22:
−23.1
FY23:
−46.9
FY24:
−4.97
FY25:
0.29
(positive)
Change from FY21 to FY25
millions USD
FY21:
−64.8
FY22:
−29.4
FY23:
−30.3
FY24:
−4.97
FY25:
−2.97
All amounts in millions USD